Rein Therapeutics Inc. (RNTX)
Market Closed
11 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 93
+0.01
+0.6087%
$
25.73M Market Cap
- P/E Ratio
- Div Yield
364,755 Volume
- Eps
$ 0.92
Previous Close Investors:
Want to track RNTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rein Therapeutics Inc. (RNTX) Statistics
Valuation metrics
Market Cap 25.73M
Enterprise value 26.84M
Trailing P/E (ttm) -0.57
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) 2.47
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.25
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 486.45K
Average volume (90 days) 614.75K
Price summary
52-Week low 0.89
52-Week high 2.18
Beta -
50-Day moving average 1.23
200-Day moving average 1.29
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 11 Nov 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.91%
Return on equity -2.58%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.15
Total debt (mrq) -
Total Debt/Equity (mrq) 0.42
Current ratio (mrq) 0.4%
Book value per share (mrq) 0.38
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
